3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
28
Burkitt Lymphoma
20
Leukemia, Myeloid, Acute
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7
Myeloproliferative Disorders
5
Myelodysplastic Syndromes
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large B-Cell, Diffuse
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myeloid, Accelerated Phase
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Leukemia, Biphenotypic, Acute
5
Hodgkin Disease
5
Congenital Abnormalities
5
Lymphoma, Large-Cell, Anaplastic
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Blast Crisis
4
Anemia, Refractory, with Excess of Blasts
4
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphoma
3
Hematologic Neoplasms
3
Chromosome 5q Deletion Syndrome
3
Breast Neoplasms
3
Waldenstrom Macroglobulinemia
2
Sezary Syndrome
2
Recurrence
2
Primary Myelofibrosis
2
Interventions
Gemcitabine
5
Cisplatin
4
enfortumab vedotin
2
Ramucirumab
2
Platinum
2
Docetaxel
2
1,2-diaminocyclohexaneplatinum II citrate
2
vinflunine
1
rucaparib
1
pembrolizumab
1
eribulin
1
enzalutamide
1
dehydroftorafur
1
carotuximab
1
avelumab
1
atezolizumab
1
Standard of Care
1
Specimen Handling
1
Radiotherapy
1
Radiation
1
Paclitaxel
1
N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide
1
Mitozytrex
1
Mitomycin
1
Magnetic Resonance Spectroscopy
1
Interleukin-7
1
Immunoglobulin G
1
Icrucumab
1
IMC-18F1
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ureteral Neoplasms
×
merphos
×
Clear all
No trials found.